Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS)

CUSIP: 00509G209

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
71,531,081
Total 13F shares
25,569,796
Share change
-246,715
Total reported value
$172,840,000
Price per share
$6.76
Number of holders
50
Value change
-$1,670,403
Number of buys
32
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 00509G209?
CUSIP 00509G209 identifies ABOS - Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS) as of Q4 2021

As of 31 Dec 2021, Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 25,569,796 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Sands Capital Ventures, LLC, BlackRock Inc., Deep Track Capital, LP, Rock Springs Capital Management LP, Laurion Capital Management LP, JANUS HENDERSON GROUP PLC, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, and GUARDIAN POINT CAPITAL, LP. This page lists 50 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.